Science

SCIENCE

Bioelectronic Medicine

Bioelectronics is a fast-growing emerging area of medicine. The human body is an electrochemical system, in which nerves carry electrical signals. Bioelectronic devices work by modulating the electrical activity in peripheral and central nerves in order to reduce symptoms and underlying causes of disease.

Play Video

A New Wave Of Electronic Medicine

Tivic Health CEO discusses the future of bioelectronic medicine at CES 2020 Digital Health Summit.

Our Approach: Non-invasive

Historically, bioelectronic medicine has relied on implanted devices. Tivic Health is focused, instead, on non-invasive approaches. Non-invasive therapies can be developed with less risk and delivered more quickly to the people who need them.

Key elements of our approach include:

  • Our patented form-factor enables low-level electrical current to penetrate deeply through tissue.
  • Proprietary algorithms detect optimal treatment zones and personalize therapeutic stimulation.
  • Programmable parameters produce varied biological responses for different diseases and conditions.
Play Video

A New Wave Of Electronic Medicine

Tivic Health CEO discusses the future of bioelectronic medicine at CES Digital Health Summit.

Pipeline

Tivic and The Feinstein Institutes for Medical Research have announced pilot study to test novel non-invasive bioelectronic approach to vagus nerve stimulation. Tivic has also filed a provisional patent for a new approach to non-invasive vagus nerve stimulation.

Our strategic goal is to advance the field of bioelectronic medicine with a more precise approach to the treatment of cardiovascular, neurological/psychiatric, and systemic inflammatory chronic health conditions without surgery, implants, or pharmaceuticals.

Additional potential clinical applications of our technology focus on stimulation of nerves of the face and head (trigeminal, vagus, facial). These include chronic quality-of-life conditions such as temporomandibular joint disorder and tinnitus; severe, life-altering conditions such as trigeminal neuralgia; and acute conditions such as ear infections.

ClearUP Regulatory Clearances

Clinical Research

Our First Product:
ClearUP® Sinus Pain Relief

Our first FDA-approved product, ClearUP® Sinus Pain Relief (“ClearUP”), is a patented handheld device that uses gentle pulsed electron waves to relieve symptoms of sinus and nasal inflammation such as sinus pain, sinus pressure, sinus headache, and congestion which can be caused by allergies, sinus infections, cold, and flu.

FIRST TRIAL1:

Demonstrated rapid relief

How does
ClearUP work?

When a user glides ClearUP along the cheek, nose, and brow bone, ClearUP emits a pulsed electron wave.

This wave stimulates the nerves that pass through the sinus passages.

Vibration guides users to the optimal treatment points to relieve sinus pain and congestion.

Subjects using ClearUP reported significant improvements (compared to sham) in sinus pain and congestion 10 minutes after use.

#p = 0.0074; *p = 0.0079; two-tailed unpaired t-test comparing Sham vs. ClearUP
10 min after treatment, patients reported relief of sinus pain
88% of patients experienced congestion relief
82% of patients prefer ClearUP over other allergy treatments
74% of patients reported pain relief on the first use

SECOND TRIAL2:

Long-term symptom relief with regular use

Subject used ClearUP at home for 4 weeks and experienced week-over-week improvements in sinus pain and congestion.

#p < 0.01, *p < 0.0001; two-tailed paired t-test comparing pre-treatment vs. post-treatment
10 min after treatment, patients reported relief of sinus pain
88% of patients experienced congestion relief
82% of patients prefer ClearUP over other allergy treatments
74% of patients reported pain relief on the first use

Peer-Reviewed Publications​

1. Microcurrent technology for rapid relief of sinus pain: a randomized, placebo‐controlled, double‐blinded clinical trial.
Maul, X. A., Borchard, N. A., Hwang, P. H., & Nayak, J. V. (2019, April). In International forum of allergy & rhinology (Vol. 9, No. 4, pp. 352-356). Read Full Paper

2. Prospective trial examining safety and efficacy of microcurrent stimulation for the treatment of sinus pain and congestion.
Goldsobel, A. B., Prabhakar, N., & Gurfein, B. T. (2019). Bioelectronic medicine, 5(1), 1-9. Read Full Paper

b911b536-f040-4f08-94a0-791e7d5a1a2a.png

The Physician's View

Play Video

Physicians share their viewpoints about ClearUP®

Subinoy Das, MD
CEO, US Institute for Advanced Sinus Care & Research

Alan Goldsobel, MD
Clinical Professor, University of California San Francisco, Allergy & Asthma Associates of Northern California,

The information included on this site reflects Tivic Health research and development pipeline and is not intended for promotional purposes. There are significant risks and uncertainties in medical device research and development.

Clinical and regulatory hurdles may cause pipeline devices to be discontinued or delayed, or to fail to reach the market. There can be no guarantee that pipeline devices will receive regulatory clearances or that they will prove to be commercially successful. Tivic Health assumes no duty to update this information.